Showing results (91-100 of 294) with videos related to
Sort By:
Pageof 30
Frontiers in Oncology|January 5, 2026
LAT1 expression in head and neck cancer: a prognostic biomarker with potential relevance for BNCTStefano Cavalieri, Imperia Nuzzolese, Deborah Lenoci, et al.Oral Oncology|July 18, 2016
Evaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancerLisa Licitra, Ulrich Keilholz, Makoto Tahara, et al.Advances in Oto-Rhino-Laryngology|July 31, 2020
Treatment Options for Recurrent Anterior Skull Base TumorsEster Orlandi, Nicola Alessandro Iacovelli, Rossana Ingargiola, et al.Oncology|September 4, 2024
Claudin-1 in Head and Neck Squamous Cell CarcinomaStefano Cavalieri, Cristiana Bergamini, Deborah Lenoci, et al.Journal of Translational Medicine|October 13, 2017
Perspectives in immunotherapy: meeting report from the "Immunotherapy Bridge", Napoli, November 30th 2016Paolo A Ascierto, Bruno Daniele, Hans Hammers, et al.Oral Oncology|January 14, 2021
The appropriate use of circulating EBV-DNA in nasopharyngeal carcinoma: Comprehensive clinical practice guidelines evaluationChiara Trevisiol, Massimo Gion, Alberto Vaona, et al.BMC Public Health|October 14, 2025
Impact of head and neck cancer on the income of Italian employeesAlessandra Macciotta, Annalisa Trama, Alice Bernasconi, et al.Future Oncology (London, England)|April 18, 2025
STELLAR-305: phase II/III study of zanzalintinib plus pembrolizumab versus pembrolizumab alone in patients with HNSCCNabil F Saba, Kevin Harrington, Lisa Licitra, et al.NMR in Biomedicine|February 4, 2020
Relevance of apparent diffusion coefficient features for a radiomics-based prediction of response to induction chemotherapy in sinonasal cancerMarco Bologna, Giuseppina Calareso, Carlo Resteghini, et al.Cancer Treatment Reviews|July 23, 2018
Optimisation of treatment with lenvatinib in radioactive iodine-refractory differentiated thyroid cancerJaume Capdevila, Kate Newbold, Lisa Licitra, et al.Pageof 30